{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:28:01Z","timestamp":1780050481941,"version":"3.53.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Azathioprine (AZA) used as an immunomodulator agent in the management of inflammatory bowel disease (IBD) increases the risk of the development of lymphoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>We present a case of a 45-year-old female receiving AZA for severe ulcerative colitis for 4 years. She presented with the chief complaints of bloody stool and abdominal pain for 1 month. Through a series of investigations including colonoscopy, contrast-enhanced computed tomography scan of the abdomen and pelvis, and biopsy with immunohistochemistry; she was diagnosed to have diffuse large B-cell lymphoma of the rectum. She is currently on a chemotherapeutic regimen and is planned for surgical resection after the completion of neoadjuvant therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>AZA is classified as a carcinogen by the International Agency for Research on Cancer. Prolonged exposure to higher doses of AZA increases the risk of developing lymphoma in IBD. Previous meta-analysis and research indicate that the risk of development of lymphoma after the use of AZA in IBD increases by about four- to six-fold, especially in older age groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>AZA may increase the susceptibility to developing lymphoma in IBD, but the benefit far outweighs the risk. Precautions must be taken in prescribing AZA in older individuals which mandates periodic screening.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000000562","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:01:31Z","timestamp":1681189291000},"page":"2059-2063","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Diffuse large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis: a case report"],"prefix":"10.1097","volume":"85","author":[{"given":"Hari","family":"Sedai","sequence":"first","affiliation":[{"name":"Maharajgunj Medical Campus, Institute of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-260X","authenticated-orcid":false,"given":"Suraj","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Maharajgunj Medical Campus, Institute of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Chand","sequence":"additional","affiliation":[{"name":"Maharajgunj Medical Campus, Institute of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Poddar","sequence":"additional","affiliation":[{"name":"Maharajgunj Medical Campus, Institute of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-2210","authenticated-orcid":false,"given":"Suman","family":"Acharya","sequence":"additional","affiliation":[{"name":"Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Koirala","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2036.2010.04330.x","article-title":"Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease","volume":"32","author":"Smith","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","article-title":"Long-term follow-up of patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine","volume":"347","author":"Bouhnik","year":"1996","journal-title":"Lancet"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.37.5.674","article-title":"A controlled double blind study of azathioprine in the management of Crohn\u2019s disease","volume":"37","author":"Candy","year":"1995","journal-title":"Gut"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/gut.2004.053231","article-title":"Risks and benefits of azathioprine therapy","volume":"54","author":"McGovern","year":"2005","journal-title":"Gut"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int J Surg"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","article-title":"Assessing severity of disease in patients with ulcerative colitis","volume":"49","author":"Pabla","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0016-5085(19)33842-9","article-title":"Mortality in ulcerative colitis: 1930 to 1966","volume":"57","author":"Morowitz","year":"1969","journal-title":"Gastroenterology"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bjs.18004720202","article-title":"The development of carcinoma of the large intestine in ulcerative colitis","volume":"47","author":"Dawson","year":"2005","journal-title":"Br J Surg"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5085(79)80119-5","article-title":"Malignant potential of chronic ulcerative colitis","volume":"76","author":"Nugent","year":"1979","journal-title":"Gastroenterology"},{"key":"R14-20250806","first-page":"355","article-title":"Peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient","volume":"8","author":"Labouyrie","year":"1995","journal-title":"Mod Pathol"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0026-895X(25)09158-8","article-title":"Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions","volume":"42","author":"Ling","year":"1992","journal-title":"Mol Pharmacol"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.M204243200","article-title":"Structure and dynamics of thioguanine-modified duplex DNA","volume":"278","author":"Somerville","year":"2003","journal-title":"J Biol Chem"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"O\u2019Donovan","year":"2005","journal-title":"Science"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bmb\/ldl020","article-title":"Thiopurines, DNA damage, DNA repair and therapy-related cancer","volume":"79-80","author":"Karran","year":"2006","journal-title":"Br Med Bull"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/190794a0","article-title":"Radiosensitization of E. coli by purine and pyrimidine analogues incorporated in deoxyribonucleic acid","volume":"190","author":"Kaplan","year":"1961","journal-title":"Nature"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/0008-5472.CAN-09-0451","article-title":"Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease","volume":"69","author":"Nguyen","year":"2009","journal-title":"Cancer Res"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","article-title":"Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer","volume":"8","author":"Karran","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.47.12.988","article-title":"Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study","volume":"47","author":"Silman","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5","article-title":"Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells","volume":"86","author":"Thomsen","year":"1999","journal-title":"Cancer"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004836-198009000-00003","article-title":"Acute myelogenous leukemia in patients with ulcerative colitis","volume":"2","author":"Fabry","year":"1980","journal-title":"J Clin Gastroenterol"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004836-198510000-00002","article-title":"Colonic lymphoma in ulcerative colitis","volume":"7","author":"Baker","year":"1985","journal-title":"J Clin Gastroenterol"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-20250806","article-title":"Diffuse Large B Cell Lymphoma. [Updated 2022 Apr 28]","author":"Martelli","journal-title":"In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan."},{"key":"R32-20250806","first-page":"1689","article-title":"6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come","volume":"91","author":"Peppercom","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R34-20250806","first-page":"e9620","article-title":"Validation of the International Prognostic Index and subsequent revisions for diffuse large B-cell lymphoma in patients from the Middle East and North Africa Region","volume":"12","author":"Alamer","year":"2020","journal-title":"Cureus"},{"key":"R35-20250806","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.mayocp.2015.04.025","article-title":"Non-Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"R36-20250806","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:31:20Z","timestamp":1754487080000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000562","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"2022-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}